Promotion of Unapproved Uses of Approved Drugs and Devices: An Analysis under the First Amendment

DSpace/Manakin Repository

Promotion of Unapproved Uses of Approved Drugs and Devices: An Analysis under the First Amendment

Citable link to this page

. . . . . .

Title: Promotion of Unapproved Uses of Approved Drugs and Devices: An Analysis under the First Amendment
Author: Morrison, Amanda M.
Citation: Promotion of Unapproved Uses of Approved Drugs and Devices: An Analysis under the First Amendment (2000 Third Year Paper)
Full Text & Related Files:
Abstract: This paper seeks (1) to provide the background necessary to understand current commercial speech jurisprudence; (2) to explore the First Amendment analysis in recent cases against FDA; (3) to examine the landscape of food and drug law and FDA’s regulation with respect to the promotion of prescription drugs and medical devices; and (4) to discuss the viability of other FDA policies on off-label promotion. In light of the recent decisions and the expansion of ways to provide information to consumers, the paper argues in favor of increased consumer access to information and the expansion of manufacturers’ ability to provide information, within certain parameters.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852115

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters